People Matter

Research Associate / Scientist - Metabolic Conditions

Moonwalk Biosciences

Moonwalk Biosciences

Posted on Friday, March 22, 2024


Moonwalk Biosciences is recruiting for Research Associate / Scientist position to join the R&D team focused on metabolic conditions including obesity and NASH. In this role, you will work closely within the R&D team to conduct biological and translational research in the area of metabolic conditions, working closely with the platform technology team to leverage Moonwalk’s epigenome engineering platform.


  • Design and implement experiments, troubleshoot technical issues, and independently conduct scientific research to identify and validate targets and determine their mechanism of action.
  • Establish critical laboratory capabilities for design and implementation of studies.
  • Close collaboration within the R&D team to achieve project objectives.
  • Detailed documentation and presentation of protocols and data.

Required Qualifications:

  • M.S./PhD in cell biology, biochemistry, pharmacology, or equivalent with 3+ years of relevant experience.
  • Demonstrated expertise to develop disease relevant in-vitro assays for metabolic conditions using cell lines, primary cells, and animal models.
  • Proficiency in cell culture techniques, including primary cell isolation, cell line maintenance, and culture.
  • Strong molecular biology skills, including qPCR, western blotting, immunofluorescence, flow cytometry, and gene editing techniques (e.g., CRISPR/Cas9).
  • Experience with genetic engineering and cellular payload delivery including transduction and transfection is preferred.
  • Strong attention to detail and impeccable organizational and documentation skills.
  • Ability to excel in a team-first, supportive work environment, and clearly articulate ideas, problems, and solutions.
  • Ability to thrive in early stage technology development with demanding schedules and deliverables.

About Moonwalk Biosciences:

Moonwalk Biosciences is pioneering a new class of precision epigenetic medicines. Its novel platform technology provides a complete view of the epigenome in health and disease, with the most advanced AI prediction of epigenetic targets, and the broadest set of epigenetic engineering tools. Moonwalk was co-founded by Alex Aravanis, M.D., Ph.D., former CTO of Illumina, world-renowned scientist Feng Zhang, Ph.D. of the Broad Institute of MIT and Harvard, and a distinguished set of industry leaders and company builders. It has raised $57 million led by Alpha Wave Ventures, and joined by other leading life sciences investors ARCH Venture Partners, Future Ventures, GV, Khosla Ventures and YK Bioventures.